document.write('<table width=100% cellspacing=1 cellpadding=3 border=0><tr><td align=\'Left\' width=100% valign=top ><font face=\'Arial\' size=\'1\' color=\'#000000\'><a href=\'http:\/\/www.uams.edu\/update\/absolutenm\/anmviewer.asp?a=9097&z=149\'><b>Specific inhibitors of Human UDP-Glucuronosyltransferases Enhance the Efficacy of Selected Antivirals by Changing their Pharmacokinetic Profiles (09-24)<\/b><\/a><\/font><a href=\'http:\/\/www.uams.edu\/update\/absolutenm\/anmviewer.asp?a=9097&z=149\'><\/a><\/font><\/td><\/tr><tr><td align=\'Left\' width=100% valign=top ><font face=\'Arial\' size=\'1\' color=\'#000000\'><a href=\'http:\/\/www.uams.edu\/update\/absolutenm\/anmviewer.asp?a=9088&z=149\'><b>Improved Pharmacokinetic Profiles of methylphenidate for ADHD (09-22)<\/b><\/a><\/font><a href=\'http:\/\/www.uams.edu\/update\/absolutenm\/anmviewer.asp?a=9088&z=149\'><\/a><\/font><\/td><\/tr><tr><td align=\'Left\' width=100% valign=top ><font face=\'Arial\' size=\'1\' color=\'#000000\'><a href=\'http:\/\/www.uams.edu\/update\/absolutenm\/anmviewer.asp?a=9085&z=149\'><b>Risk&#8211;adapted therapy for multiple myeloma patents harboring the TP53 Deletion:  The adverse consequences in Total Therapy 2 are overcome by addition of Bortezomib in Total Therapy 3 to treat the disease (09-30 CIP 07-06)<\/b><\/a><\/font><a href=\'http:\/\/www.uams.edu\/update\/absolutenm\/anmviewer.asp?a=9085&z=149\'><\/a><\/font><\/td><\/tr><tr><td align=\'Left\' width=100% valign=top ><font face=\'Arial\' size=\'1\' color=\'#000000\'><a href=\'http:\/\/www.uams.edu\/update\/absolutenm\/anmviewer.asp?a=9010&z=149\'><b>Vascular Clip and Devices for Sutureless Anastomosis and Bypasses  (08-31)<\/b><\/a><\/font><a href=\'http:\/\/www.uams.edu\/update\/absolutenm\/anmviewer.asp?a=9010&z=149\'><\/a><\/font><\/td><\/tr><tr><td align=\'Left\' width=100% valign=top ><font face=\'Arial\' size=\'1\' color=\'#000000\'><a href=\'http:\/\/www.uams.edu\/update\/absolutenm\/anmviewer.asp?a=8972&z=149\'><b>UAMS Startup Companies<\/b><\/a><\/font><a href=\'http:\/\/www.uams.edu\/update\/absolutenm\/anmviewer.asp?a=8972&z=149\'><\/a><\/font><\/td><\/tr><tr><td align=\'Left\' width=100% valign=top ><font face=\'Arial\' size=\'1\' color=\'#000000\'><a href=\'http:\/\/www.uams.edu\/update\/absolutenm\/anmviewer.asp?a=8967&z=149\'><b>Human intestinal regions and characterized subcellular factions from duodenum, small intestine and the colon (99-22)<\/b><\/a><\/font><a href=\'http:\/\/www.uams.edu\/update\/absolutenm\/anmviewer.asp?a=8967&z=149\'><\/a><\/font><\/td><\/tr><tr><td align=\'Left\' width=100% valign=top ><font face=\'Arial\' size=\'1\' color=\'#000000\'><a href=\'http:\/\/www.uams.edu\/update\/absolutenm\/anmviewer.asp?a=8937&z=149\'><b>Metabolic profiling methods and compositions to control Warfarin therapy:  personalized medicine for control of coagulation therapy (09-26)<\/b><\/a><\/font><a href=\'http:\/\/www.uams.edu\/update\/absolutenm\/anmviewer.asp?a=8937&z=149\'><\/a><\/font><\/td><\/tr><tr><td align=\'Left\' width=100% valign=top ><font face=\'Arial\' size=\'1\' color=\'#000000\'><a href=\'http:\/\/www.uams.edu\/update\/absolutenm\/anmviewer.asp?a=8843&z=149\'><b>Uses for Human UGT-glucuronosyltransferases to enhance pain control by Cannabinoids and possible activation of classical cannabinoids: a new class API derivatives (09-23)<\/b><\/a><\/font><a href=\'http:\/\/www.uams.edu\/update\/absolutenm\/anmviewer.asp?a=8843&z=149\'><\/a><\/font><\/td><\/tr><tr><td align=\'Left\' width=100% valign=top ><font face=\'Arial\' size=\'1\' color=\'#000000\'><a href=\'http:\/\/www.uams.edu\/update\/absolutenm\/anmviewer.asp?a=8816&z=149\'><b>Liposome Carrier for Site Specific Delivery of chemotheraprtic, polypeptides, toxins radiotherapeutic and radiosensitizing agents (09-07)<\/b><\/a><\/font><a href=\'http:\/\/www.uams.edu\/update\/absolutenm\/anmviewer.asp?a=8816&z=149\'><\/a><\/font><\/td><\/tr><tr><td align=\'Left\' width=100% valign=top ><font face=\'Arial\' size=\'1\' color=\'#000000\'><a href=\'http:\/\/www.uams.edu\/update\/absolutenm\/anmviewer.asp?a=8804&z=149\'><b>Polymer Material for Surgical Training of Tumor Excision (09-20)<\/b><\/a><\/font><a href=\'http:\/\/www.uams.edu\/update\/absolutenm\/anmviewer.asp?a=8804&z=149\'><\/a><\/font><\/td><\/tr><tr><td align=\'Left\' width=100% valign=top ><font face=\'Arial\' size=\'1\' color=\'#000000\'><a href=\'http:\/\/www.uams.edu\/update\/absolutenm\/anmviewer.asp?a=8730&z=149\'><b>BiliSuit &#8211; a Fiber optic LED form fitting garment for treatment of infant hyperbilirubinemia (09-03)<\/b><\/a><\/font><a href=\'http:\/\/www.uams.edu\/update\/absolutenm\/anmviewer.asp?a=8730&z=149\'><\/a><\/font><\/td><\/tr><tr><td align=\'Left\' width=100% valign=top ><font face=\'Arial\' size=\'1\' color=\'#000000\'><a href=\'http:\/\/www.uams.edu\/update\/absolutenm\/anmviewer.asp?a=8731&z=149\'><b>Bortezomib (Velcade) Induces Osteoblast Differentiation via a Wnt-Independent Activation of Beta-Catenin\/TCF Signaling: new target for bone formation (09-04)<\/b><\/a><\/font><a href=\'http:\/\/www.uams.edu\/update\/absolutenm\/anmviewer.asp?a=8731&z=149\'><\/a><\/font><\/td><\/tr><tr><td align=\'Left\' width=100% valign=top ><font face=\'Arial\' size=\'1\' color=\'#000000\'><a href=\'http:\/\/www.uams.edu\/update\/absolutenm\/anmviewer.asp?a=7930&z=149\'><b>Preparation Methods for Biodegradable Micro-Particles Containing Polypeptide Drugs &#8211; non-organic suspension &#8211; encapsulation techniques (08-34)<\/b><\/a><\/font><a href=\'http:\/\/www.uams.edu\/update\/absolutenm\/anmviewer.asp?a=7930&z=149\'><\/a><\/font><\/td><\/tr><\/table>');